临床药师对2例色素失禁症新生儿的药学监护OA

Objective To explore the key points of monitoring for clinical pharmacists in the anti-infection and analgesic treatment of neonatal patients with incontinentia pigmenti.Methods By reviewing domestic and international literature,clinical pharmacists provided evidence-based guidance on the anti-infective and analgesic treatment of two neonates with incontinentia pigmenti,and monitored the effectiveness and safety of drug treatment in the children.Results The skin lesions of the two children improved significantly compared with before,the pain score decreased,and there were no obvious adverse drug reactions.Conclusion Clinical pharmacists provided individualized medication recommendations for local or systemic anti-infection treatment and analgesic regimens for neonates with incontinentia pigmenti,which provided a reference for the treatment of this rare disease.